Flexion Therapeutics (FLXN)

9.12  -0.02 (-0.22%)

After market: 9.121 +0 (+0.01%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2021-9-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
100.40M85.55M72.96M22.52M360.00K
Cost Of Goods
21.16M19.25M9.96M7.34M0.00
Gross Profit
79.25M66.30M63.00M15.19M350.00K
Operating Expenses
157.72M159.32M199.27M174.39M130.04M
Research and Development
52.08M54.33M69.56M53.08M51.23M
Selling, General, and Administrative Expenses
105.66M105.00M129.71M121.31M78.80M
Operating Income
-78.48M-93.02M-136.27M-159.20M-129.68M
Interest Income/Expense
-21.02M-19.15M-13.85M-11.15M-7.55M
Other Income/Expense
-1.73M-1.04M350.00K690.00K-250.00K
Income Before Taxes
-100.73M-113.21M-149.77M-169.66M-137.48M
Income Tax
N/A500.00KN/AN/AN/A
Net Income
-100.73M-113.71M-149.77M-169.66M-137.48M
EBITDA
-76.51M-91.32M-135.21M-157.49M-127.67M
 
Per Share Data
EPS Diluted Total Ops
-2.02-2.53-3.93-4.49-4.16
Non GAAP EPS
N/A-2.61-3.93-4.48-4.16
 
Statistics
Gross Profit Margin
78.93%77.50%86.35%67.45%97.22%
Profit Margin
-100.33%-132.92%-205.28%-753.37%-38188.89%
Operating Profit Margin
-78.17%-108.73%-186.77%-706.93%-36022.22%

All data in USD

Charts